We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRDS
4676
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$15.6K ﹤0.01%
9,219
+7,204
+358% +$9.13K
SID icon
4677
Companhia Siderúrgica Nacional
SID
$1.31B
$15.6K ﹤0.01%
5,640
KEEL
4678
Keel Infrastructure Corp
KEEL
$2.4B
$15.5K ﹤0.01%
35,300
+8,500
+32% +$6.26K
TOI icon
4679
The Oncology Institute
TOI
$486M
$15.4K ﹤0.01%
9,343
+7,868
+533% +$22.1K
RGTI icon
4680
Rigetti Computing
RGTI
$4.97B
$15.4K ﹤0.01%
21,097
+19,685
+1,394% +$28.1K
NL icon
4681
NLI Holdings
NL
$281M
$15.3K ﹤0.01%
2,245
+1,875
+507% +$14K
ONDS icon
4682
Ondas Inc
ONDS
$4.27B
$15.2K ﹤0.01%
9,555
+8,046
+533% +$23.6K
AOMR
4683
Angel Oak Mortgage REIT
AOMR
$220M
$15.2K ﹤0.01%
3,204
+2,698
+533% +$22.3K
BLUA
4684
DELISTED
BlueRiver Acquisition Corp.
BLUA
$15.1K ﹤0.01%
1,500
-100,000
-99% -$1,000K
HPLT
4685
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
$15K ﹤0.01%
1,500
TCI icon
4686
Transcontinental Realty Investors
TCI
$352M
$15K ﹤0.01%
339
+286
+540% +$11.9K
BODI icon
4687
The Beachbody Company
BODI
$70.6M
$14.8K ﹤0.01%
562
+473
+531% +$20.5K
THRD
4688
DELISTED
Third Harmonic Bio
THRD
$14.6K ﹤0.01%
3,394
-25,356
-88% -$424K
STSA
4689
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$14.3K ﹤0.01%
15,893
-203,009
-93% -$588K
CNTG
4690
DELISTED
Centogene N.V. Common Shares
CNTG
$14.3K ﹤0.01%
15,348
-310
-2% -$282
VHI icon
4691
Valhi
VHI
$380M
$14.3K ﹤0.01%
648
+546
+535% +$13.3K
ZPTAW
4692
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$14.1K ﹤0.01%
200,000
NGC
4693
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$13.9K ﹤0.01%
1,385
VHT icon
4694
Vanguard Health Care ETF
VHT
$18.1B
$13.6K ﹤0.01%
55
ATER icon
4695
Aterian
ATER
$4.45M
$13.6K ﹤0.01%
1,476
+1,243
+533% +$15.6K
KNSW.WS
4696
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$13.5K ﹤0.01%
300,000
TRML
4697
DELISTED
Tourmaline Bio
TRML
$13.5K ﹤0.01%
1,324
+521
+65% +$8.37K
ORGS
4698
DELISTED
Orgenesis Inc. Common Stock
ORGS
$13.4K ﹤0.01%
688
-2
-0.3% -$34
FOA icon
4699
Finance of America Companies
FOA
$203M
$13.4K ﹤0.01%
1,053
+888
+538% +$13K
LYLT
4700
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$13.2K ﹤0.01%
5,483
+4,537
+480% +$7.77K

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.